Product Introduction:
Nxtclav 200/125 mg Tablet contains Cefpodoxime Proxetil (200 mg) and Clavulanic Acid (125 mg). Cefpodoxime is a third-generation cephalosporin antibiotic that inhibits bacterial cell wall synthesis, while Clavulanic Acid is a beta-lactamase inhibitor that protects Cefpodoxime from being broken down by resistant bacteria. This combination is highly effective in managing respiratory tract infections, skin infections, urinary tract infections, and ENT infections.
Uses:
-
Respiratory tract infections (bronchitis, pneumonia)
-
Sinusitis and tonsillitis
-
Ear infections (otitis media)
-
Urinary tract infections
-
Skin and soft tissue infections
Benefits:
-
Broad-spectrum activity against resistant bacteria
-
Effective in treating both gram-positive and gram-negative infections
-
Helps prevent bacterial resistance
-
Convenient oral dosage for outpatient treatment
Composition (per tablet):
-
Cefpodoxime Proxetil 200 mg
-
Clavulanic Acid 125 mg
Side Effects:
-
Nausea or vomiting
-
Diarrhea
-
Abdominal pain
-
Headache
-
Rash or allergic reactions (rare)
Safety Advice:
-
Take after food to enhance absorption and reduce stomach upset
-
Complete the full course, even if symptoms improve early
-
Inform your doctor if you have a history of allergy to cephalosporins or penicillins
-
Use with caution in patients with liver or kidney conditions
-
Not recommended in pregnancy or breastfeeding unless advised by a healthcare provider
-
Store in a cool, dry place away from moisture and sunlight
